These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 17102158

  • 21. Primary care diabetes. What options are there?
    Yeap BB.
    Aust Fam Physician; 2001 Dec; 30(12):1122-8. PubMed ID: 11838389
    [Abstract] [Full Text] [Related]

  • 22. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
    Nadeau DA.
    Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
    [Abstract] [Full Text] [Related]

  • 23. Time to insulin in type-2 diabetes: high hurdles or Santiago way?
    Rotella CM, Pala L.
    Acta Diabetol; 2008 Jun; 45(2):67-74. PubMed ID: 18408882
    [Abstract] [Full Text] [Related]

  • 24. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 25. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown A, Guess N, Dornhorst A, Taheri S, Frost G.
    Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408
    [Abstract] [Full Text] [Related]

  • 26. [Insulin and weight gain: myth or reality?].
    Larger E, Rufat P, Dubois-Laforgue D, Ledoux S.
    Diabetes Metab; 2001 Nov; 27(5 Pt 3):S23-7. PubMed ID: 11910976
    [Abstract] [Full Text] [Related]

  • 27. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study.
    Rigalleau V, Delafaye C, Baillet L, Vergnot V, Brunou P, Gatta B, Gin H.
    Diabetes Metab; 1999 Sep; 25(4):321-8. PubMed ID: 10566121
    [Abstract] [Full Text] [Related]

  • 28. Diabetes and weight management.
    Lau DC.
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S24-30. PubMed ID: 20394888
    [Abstract] [Full Text] [Related]

  • 29. Medication associated with weight gain may influence outcome in a weight management program.
    Malone M, Alger-Mayer SA, Anderson DA.
    Ann Pharmacother; 2005 Apr; 39(7-8):1204-8. PubMed ID: 15928261
    [Abstract] [Full Text] [Related]

  • 30. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain?
    Ryan M, Livingstone MB, Ducluzeau PH, Sallé A, Genaitay M, Ritz P.
    Diabetes Care; 2008 Mar; 31(3):448-50. PubMed ID: 18086874
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 32. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ, Cohen H, Chu V.
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [Abstract] [Full Text] [Related]

  • 33. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S, Alvarsson M, Brismar K, Wagner H.
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [Abstract] [Full Text] [Related]

  • 34. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
    Schwartz MS, Chadha A.
    J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
    [Abstract] [Full Text] [Related]

  • 35. Insulin therapy in type 2 diabetes.
    Wyne KL, Mora PF.
    Endocr Res; 2007 Sep; 32(3):71-107. PubMed ID: 18092196
    [No Abstract] [Full Text] [Related]

  • 36. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 37. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 38. The stepwise approach to the management of type 2 diabetes.
    Warren RE.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [Abstract] [Full Text] [Related]

  • 39. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 40. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.